Chordate Medical Holding AB (publ) (CMH.ST) Research

Established in 2005 and based in Kista, Sweden, Chordate Medical Holding AB (publ) is a medical technology company. This firm concentrates on developing products and solutions for the treatment of chronic migraine and rhinitis. Its specialization lies within the ear-nose and throat (ENT) area, with its operations primarily conducted in Sweden.

Market snapshot

Symbol
CMH.ST
Price
$0.10
Day change
-37.50%
Market cap
$270.0K
P/E ratio
-0.01x
52-week range
0.08-16
Sector
Healthcare
Industry
Medical - Devices

Peer companies

  • Episurf Medical AB (publ) (EPIS-B.ST)
  • Fluicell AB (publ) (FLUI.ST)
  • Gabather AB (publ) (GABA.ST)
  • LIDDS AB (publ) (LIDDS.ST)
  • ProstaLund AB (publ) (PLUN.ST)
  • Prostatype Genomics AB (publ) (PROGEN.ST)
  • Quia Pharma AB (publ) (QUIA.ST)
  • S2Medical AB (publ) (S2M.ST)

Open Chordate Medical Holding AB (publ) (CMH.ST) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.